InsidersTradesSigma
Browse the full record of transactions filed by Sofia Heigis, Chief Executive Officer. Director active across 2 companies, notably Oncopeptides AB. In total, 1 filings have been published. History available since 17 March 2026. The latest transaction was filed on 17 March 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration
Sofia Heigis is the CEO of Oncopeptides AB. She is responsible for the strategic and operational direction of the company, ensuring its development and performance in the market.